Dräger recently announced that it has acquired a majority stake in Swiss medtech startup Stimit and its noninvasive tech to stimulate intensive care patients’ respiratory muscles. The financial terms of the deal were not disclosed in the April 1 announcement. Stimit will work with Dräger in the following months to further develop the product and […]